IP Verse

Improved T Cell Manufacturing Process

Patent No. EP3880802 (titled "Improved T Cell Manufacturing Process") was filed by Celgene on Nov 15, 2019. The application was issued on Sep 7, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTJun 7, 2023BOULT WADE TENNANT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3880802

CELGENE
Application Number
EP19821337A
Filing Date
Nov 15, 2019
Status
Revoked
Aug 1, 2025
Publication Date
Sep 7, 2022
External Links
Slate, Register , Google Patents